The effect of campylobacter lipopolysaccharide on fetal development in the mouse

References

1. Armitage P. 1971; Statistical methods in medical research. Blackwell Scientific; Oxford:
   [Google Scholar]
2. Coid C. R. 1976; Bacterial endotoxin and impaired fetal development. Experientia 32:735–736
   [Google Scholar]
3. Fumarola D., Miragliotta G., Jirillo E. 1982; Endotoxin-like activity associated with heat-killed organisms of the genus Campylobacter. In Newell D. G. (ed) Campylobacter: epidemiology, pathogenesis and biochemistry MTP Press; Lancaster: pp 185–187
   [Google Scholar]
4. Hitchcock P. J., Brown T. M. 1983; Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. Journal of Bacteriology 154:269–277
   [Google Scholar]
5. Johnson K. G., Perry M. B. 1976; Improved techniques for the preparation of bacterial lipopolysaccharides. Canadian Journal of Microbiology 22:29–34
   [Google Scholar]
6. Liideritz O., Freudenberg M. A., Galanos C., Lehmann V., Rietschel E. T., Shaw D. H. 1982; Lipopolysaccharides of gram-negative bacteria. Current Topics in Membranes and Transport 17:79–151
   [Google Scholar]
7. Maniatis T., Fritsch E. F., Sambrook J. 1982; Molecular cloning. A laboratory manual Cold Spring Harbor Laboratory, Cold Spring Harbor; NY:
   [Google Scholar]
8. Naess V., Hofstad T. 1984; Chemical composition and biological activity of lipopolysaccharides prepared from type strains of Campylobacter jejuni and Campylobacter coli. Acta Pathologica Microbiologica et Immunologica Scandinavica, Section B 92:217–222
   [Google Scholar]
9. Osborne J. C. 1965; Pathological responses in animals after Vibrio fetus toxin shock. American Journal of Veterinary Research 26:1056–1067
   [Google Scholar]
10. Osborne J. C., Smibert R. M. 1964; Vibrio fetus toxin. 1. Hypersensitivity and abortifacient action. The Cornell Veterinarian 54:561–572
    [Google Scholar]
11. O’Sullivan A. M., Dore C., Coid C. R. 1988; Campylobacters and impaired fetal development in mice. Journal of Medical Microbiology 25:7–12
    [Google Scholar]
12. Perez-Perez G. I., Blaser M. J. 1985; Lipopolysaccharide characteristics of pathogenic Campylobacters. Infection and Immunity 47:353–359
    [Google Scholar]
13. Perez-Perez G. I., J A., Blaser M. J. 1986; Lipopolysaccharide structures in Enterobacteriaceae, Pseudomonas aeruginosa and Vibrio cholerae are immunologically related to Campylobacter spp. Infection and Immunity 51:204–208
    [Google Scholar]
14. Ross G. J. S. 1980; MLP–Maximum Likelihood Program. Rothamsted Experimental Station Harpenden:
    [Google Scholar]
15. Shands J. W. 1971; The physical structure of bacterial lipopolysac-charides. In Weinbaum G. (eds) vol 6 Bacterial endotoxins Microbial toxins, Academic Press; London: pp 127–144
    [Google Scholar]
16. Skirrow M. B. 1984; Campylobacter infections of man. In Easmon C. S. F., Jeljaszewicz J. (eds) Medical microbiology vol 4 Academic Press; London: pp 105–141
    [Google Scholar]
17. Smith H. 1978; The determinants of microbial pathogenicity. In Norris J. R., Richmond M. H. (eds) Essays in microbiology chapter 13 John Wiley and Sons; Chichester: pp 13/1–13/32
    [Google Scholar]